Evaxion Biotech
4 Followers
About
Evaxion is pioneering the field of immunoinformatics, working hard to bring novel, highly effective vaccines and antibodies to patients. By converting complex immunological data into computational algorithms, Evaxion is capable of programming the immune system to fight off a variety of diseases from cancers to hard-to-treat anti-microbial resistant infections.
- Website
- Headquarters
- Industry
- Social
People
View all (19)
Lars Wegner
CEO
Andreas Holm Mattsson
CSO and co-founder
Birgitte Rønø
Director, Cancer Vaccines
Glenn Vraniak
CFO
Jens Kringelum
Director, Genomic Immuno-Oncology
Niels Moeller
COO and Co-founder
Pär Comstedt
Director, Infectious Disease Vaccines
Marianne Søgaard
Chairwoman of the Board
Roberto Prego Pineda
Board Member
Steven Projan
Board Member
Søren Brunak
Scientific Advisor
Jeffrey S. Weber
Advisor
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.